Can the FDA Go Public with Proprietary Information?

On 19 May 2010, a FDA task force proposed 21 ways that the Agency could release more information to the public in areas like drug evaluation, including information about safety problems with the drugs and devices it rejects.  Although the FDA has long operated under...

Strengthening the business of personalized medicine

In general, drugs often work in only half of the people who take them.  In addition, billions are spent to treat adverse drug reactions and other complications.  The personalized medicine approach is to elucidate the differences between patients who respond to a drug...

Drug Pharmacokinetic Comparison between Humans and Monkeys

To verify the availability of pharmacokinetic parameters in cynomolgus monkeys, hepatic availability (Fh) and the fraction absorbed (Fa) multiplied by intestinal availability (Fg) were evaluated to determine their contributions to absolute bioavailability (F) after...